Human Lymphoid Tissue Inducers
Human Lymphoid Tissue Inducers
批准号:
8020148
负责人:
Carl F Ware
金额:
$28.36万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2012-07-31
关键词:
AddressAdultBiochemicalBiological AssayCD30LCell LineCell LineageCell ProliferationCell SeparationCellsCharacteristicsChronicCoculture TechniquesCytokine SignalingDendritic CellsDifferentiation InducerDiseaseEmbryoEvaluationGene ExpressionGene Expression ProfileGenesGoalsGovernmentHandHelper-Inducer T-LymphocyteHematopoieticHomeostasisHumanHypersensitivityIL7 geneImmuneImmune responseImmunologyIn VitroInfectionInflammationInflammatory ResponseInstitutesInterleukin-17Interleukin-7IntestinesInvestigationLeftLeukocytesLymphoidLymphoid TissueMemoryMethodsMolecularMolecular ProfilingMusOrganPatternPersonsPlayPopulationProcessPropertyResearchRoleSignal TransductionSiteSpeedSpleenStructure of aggregated lymphoid follicle of small intestineSystemSystems BiologyTechniquesTumor Necrosis Factor-Betablastomere structurecytokineimmune functionin vivoin vivo Modellymph nodespathogenperipheral bloodreceptorreconstitutionresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Lymphoid tissue inducer (LTi) cells represent a rare hematopoietic cell lineage that has emerged as a key regulator of lymphoid tissue homeostasis. LTi cells were originally identified as an essential cell that initiates the embryonic formation of secondary lymphoid organs, including lymph nodes and intestinal Peyer's patches. This distinct lineage of cells persists in the adult and appears to play a critical role in the homeostasis of lymphoid organs following inflammatory responses. LTi cells are also implicated in formation of tertiary lymphoid aggregates at sites of chronic inflammation, and may be critical for controlling dendritic cell proliferation. LTi cells are extremely rare, typically less than 0.5% cells in the adult mouse spleen, making investigation into their function extremely difficult. Almost nothing is known about the LTi lineage in humans and their role in immune function. The lack of culture systems to grow these cells in pure populations has severely hampered investigations into the function of LTi cells. We have recently isolated human LTi from peripheral blood using high speed cell sorting, and identified culture conditions that allow LTi to survive, expand and differentiate in response to cytokine signals. The cultured, putative human LTi cells respond to IL-7 by induction of lymphotoxin (LT)-¿ and CD30 ligand, key cytokines required for lymphoid homeostasis and immune memory. IL7 also induced IL17A and RORc implicating expansion of adult human LTi cells with gene expression profile similar to mouse LTi cells. This discovery will allow assessment of the role of LTi cells in immune responses and identify new strategies in treating disease. To accomplish this goal we will characterize the gene expression patterns of human LTi cells in response to cytokines, and with pure population of cells determine their immune regulatory properties.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Overriding the Immune Evasion Tactics of Coronavirus
-
批准号:10237419
-
项目类别:
-
资助金额:$61.8万
-
财政年份:2020
-
负责人:Carl F Ware
-
依托单位:
Overriding the Immune Evasion Tactics of Coronavirus
-
批准号:10671613
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2020
-
负责人:Carl F Ware
-
依托单位:
Overriding the Immune Evasion Tactics of Coronavirus
-
批准号:10188930
-
项目类别:
-
资助金额:$61.8万
-
财政年份:2020
-
负责人:Carl F Ware
-
依托单位:
Overriding the Immune Evasion Tactics of Coronavirus
-
批准号:10454292
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2020
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA Pathway in Lymphoma
-
批准号:8700133
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2012
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA Pathway in Lymphoma
-
批准号:8534744
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2012
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA Pathway in Lymphoma
-
批准号:8370219
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2012
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA Pathway in Lymphoma
-
批准号:9081538
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2012
-
负责人:Carl F Ware
-
依托单位:
MODULATING LYMPHOTOXINS IN PRIMATES FOR VIRAL DEFENSES
-
批准号:8357268
-
项目类别:
-
资助金额:$19.14万
-
财政年份:2011
-
负责人:Carl F Ware
-
依托单位:
Human Lymphoid Tissue Inducers
-
批准号:8136779
-
项目类别:
-
资助金额:$17.19万
-
财政年份:2010
-
负责人:Carl F Ware
-
依托单位:
MODULATING LYMPHOTOXINS IN PRIMATES FOR VIRAL DEFENSES
-
批准号:8172541
-
项目类别:
-
资助金额:$15.21万
-
财政年份:2010
-
负责人:Carl F Ware
-
依托单位:
Human Lymphoid Tissue Inducers
-
批准号:7874791
-
项目类别:
-
资助金额:$6.62万
-
财政年份:2010
-
负责人:Carl F Ware
-
依托单位:
MODULATING LYMPHOTOXINS IN PRIMATES FOR VIRAL DEFENSES
-
批准号:7959029
-
项目类别:
-
资助金额:$14.66万
-
财政年份:2009
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in inflammation
-
批准号:8143923
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in Inflammation
-
批准号:8890072
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in inflammation
-
批准号:7848859
-
项目类别:
-
资助金额:$10.63万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in inflammation
-
批准号:7264400
-
项目类别:
-
资助金额:$47.45万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in inflammation
-
批准号:7413616
-
项目类别:
-
资助金额:$46.55万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in Inflammation
-
批准号:8507113
-
项目类别:
-
资助金额:$47.35万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in inflammation
-
批准号:7614417
-
项目类别:
-
资助金额:$46.55万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
海外基金